Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00671073 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Oglemilast
DRUG: Placebo
DRUG: Oglemilast
DRUG: Oglemilast

Sponsor

Forest Laboratories